Grove Bank & Trust Grows Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Grove Bank & Trust lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 550 shares of the pharmaceutical company’s stock after buying an additional 32 shares during the quarter. Grove Bank & […]

Related Keywords

Canada ,Stifel Nicolaus ,Robertw Baird ,Stuarta Arbuckle ,Kristen Ambrose ,News Ratings For Vertex Pharmaceuticals Daily ,Maxim Group ,Man Group ,Vertex Pharmaceuticals Incorporated ,Vertex Pharmaceuticals ,Quarter For Vertex Pharmaceuticals ,Macquarie Group Ltd ,Vertex Pharmaceuticals Price Performance ,Vertex Pharmaceuticals Company Profile ,Jennison Associates ,Barclays ,Grove Bank ,Securities Exchange Commission ,Norges Bank ,Morgan Stanley ,Royal Bank ,Free Report ,Exchange Commission ,Pharmaceuticals Incorporated ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,